QUEoncology Healthier menopause treatments
Atlanta, US · 2 known investors
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
Investors · 2
Frequently asked questions
- What does QUEoncology Healthier menopause treatments do?
- QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
- Who are QUEoncology Healthier menopause treatments's investors?
- QUEoncology Healthier menopause treatments's investors include Brandon BioCatalyst, Stoic VC.
- Where is QUEoncology Healthier menopause treatments headquartered?
- QUEoncology Healthier menopause treatments is headquartered in Atlanta, US.